All In Biotech

Free tool

FAERS Monitor: Concerta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021121 or its brand name (Concerta, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

24,565

Serious

15,132

62% of reports

Hospitalization

5,015

Death reported

790

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,748
  • headache1,273
  • off label use1,230
  • nausea1,120
  • fatigue1,103
  • anxiety1,100
  • insomnia907
  • depression825
  • suicidal ideation825
  • decreased appetite755
  • aggression720
  • disturbance in attention720
  • somnolence697
  • dizziness693
  • vomiting687

Reports by year received

View as table
YearReports
2004501
2005509
2006503
2007554
2008549
2009622
2010619
2011561
2012669
2013626
2014639
20152,084
20161,658
20171,486
20181,417
20191,422
20201,208
20211,069
20221,607
20231,970
20241,631
20251,550
20261,111

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,594 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
aggressionSignal72012.511.67,502
disturbance in attentionSignal72011.610.86,868
suicidal ideationSignal8257.87.34,843
anxietySignal1,1003.33.11,797
depressionSignal8253.12.91,189
somnolenceSignal6973.02.8915
insomniaSignal9072.92.71,156
decreased appetiteSignal7552.82.6871
drug ineffective2,7481.81.71,013
headache1,2731.71.6411
vomiting6871.31.235
fatigue1,1031.21.143
nausea1,1201.21.143
off label use1,2301.21.144
dizziness6931.21.121

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.